SCHEMBL7703452

SCHEMBL7703452

CSCC[C@H](NC(=O)c1ccc(C=C(Cn2ccnc2)c2nccs2)cc1-c1ccsc1)C(=O)O

nearest known ligand 0.48

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FNTA P49354 11/20 0.48
FNTB P49356 11/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7703446 1.00 FNTA (0.48) FNTAFNTB
SCHEMBL8198535 0.93 FNTA (0.54) FNTAFNTB
SCHEMBL8205645 0.93 FNTA (0.54) FNTAFNTB
SCHEMBL7706180 0.93 FNTA (0.51) FNTAFNTB
SCHEMBL7706173 0.93 FNTA (0.51) FNTAFNTB
SCHEMBL7703362 0.91 FNTA (0.48) FNTAFNTB
SCHEMBL7703365 0.91 FNTA (0.48) FNTAFNTB
SCHEMBL8222051 0.89 FNTA (0.37) FNTAFNTB
SCHEMBL8222046 0.89 FNTA (0.37) FNTAFNTB
SCHEMBL8206449 0.84 FNTA (0.45) FNTAFNTB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414145-B1 TREATING CANCER AND NEUROFIBROMATOSIS ZENECA LIMITED (GB) 2002-07-02 US claimed
US-6414145-B1 TREATING CANCER AND NEUROFIBROMATOSIS ZENECA LIMITED (GB) 2002-07-02 US disclosed
EP-0975603-A1 INHIBITORS OF FARNESYL PROTEIN TRANSFERASE ZENECA LIMITED (GB) 2000-02-02 EP disclosed
WO-1998032741-A1 INHIBITORS OF FARNESYL PROTEIN TRANSFERASE ZENECA LIMITED (GB) 1998-07-30 WO disclosed